The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow

被引：0
|
作者：
W Ingram
N C Lea
J Cervera
U Germing
P Fenaux
B Cassinat
J J Kiladjian
J Varkonyi
P Antunovic
N B Westwood
M J Arno
A Mohamedali
J Gaken
T Kontou
B H Czepulkowski
N A Twine
J Tamaska
J Csomer
S Benedek
N Gattermann
E Zipperer
A Giagounidis
Z Garcia-Casado
G Sanz
G J Mufti
机构：
[1] Kings College Hospital and Kings College London,Department of Haematological Medicine
[2] The Servicio de Hematologia y Hemoterapia,Department of Haematology
[3] Hospital Universitario La Fe,Third Department of Internal Medicine
[4] Oncology and Clinical Immunology,Department of Haematology
[5] Heinrich-Heine-University,Department of Oncology and Clinical Immunology
[6] Hematology Department at Hopital Avicenne,undefined
[7] Semmelweis University,undefined
[8] University Hospital Linköping,undefined
[9] Genomics center,undefined
[10] School of Biomedical and Health Sciences,undefined
[11] Kings College London,undefined
[12] National Health Centre,undefined
[13] Semmelweis University,undefined
[14] Institute of Pathology and Cancer Research,undefined
[15] Semmelweis University,undefined
[16] St-Johannes-Hospital,undefined
来源：
Leukemia | 2006年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1319 / 1321
页数：2
相关论文
共 50 条
  • [21] The JAK2 V617F mutation in breast cancer?
    Naeem, Mohammad Abdul
    BREAST JOURNAL, 2020, 26 (03): : 593 - 593
  • [22] The V617F JAK2 mutation and the myeloproliferative disorders
    Percy, MJ
    McMullin, MF
    HEMATOLOGICAL ONCOLOGY, 2005, 23 (3-4) : 91 - 93
  • [23] JAK2 (V617F) mutation in patients with chronic myeloproliferative disorders
    Hamidah, N.
    Farisah, N.
    Jalil, N.
    Fei-Liang, W.
    AWahid, F.
    Othman, A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 : 121 - 122
  • [24] JAK2 V617F MUTATION SCANNING IN PATIENTS WITH ADRENAL INCIDENTALOMA
    Ekinci, F.
    Soyaltin, U. E.
    Kutbay, Y. B.
    Yasar, H. Y.
    Yildirim, T. Demirci
    Akar, H.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2017, 13 (02) : 150 - 153
  • [25] Absence of JAK2 V617F mutation in thalassemia intermedia patients
    Taher, Ali
    Shammaa, Dina
    Bazarbachi, Ali
    Itani, Doha
    Zaatari, Ghazi
    Greige, Layal
    Otrock, Zaher K.
    Mahfouz, Rami A. R.
    MOLECULAR BIOLOGY REPORTS, 2009, 36 (06) : 1555 - 1557
  • [26] Absence of JAK2 V617F mutation in thalassemia intermedia patients
    Ali Taher
    Dina Shammaa
    Ali Bazarbachi
    Doha Itani
    Ghazi Zaatari
    Layal Greige
    Zaher K. Otrock
    Rami A. R. Mahfouz
    Molecular Biology Reports, 2009, 36 : 1555 - 1557
  • [27] The JAK2 V617F mutation in patients with cerebral venous thrombosis
    Passamonti, S. M.
    Biguzzi, E.
    Cazzola, M.
    Franchi, F.
    Gianniello, F.
    Bucciarelli, P.
    Pietra, D.
    Mannucci, P. M.
    Martinelli, I.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (06) : 998 - 1003
  • [28] THE INVESTIGATION OF 621 PATIENTS SCREENED FOR THE JAK2 V617F MUTATION
    Toylu, A.
    Salim, O.
    Timuragaoglu, A. Irfanoglu
    HAEMATOLOGICA, 2012, 97 : 549 - 549
  • [29] The incidence of the JAK2 V617F mutation in patients with idiopathic erythrocytosis
    Percy, Melanie J.
    Jones, Frank G. C.
    Green, Anthony R.
    Reilly, John T.
    McMullin, Mary Frances
    HAEMATOLOGICA, 2006, 91 (03) : 413 - 414
  • [30] The V617F mutation of JAK2 is very uncommon in patients with thrombosis
    Remacha, Angel F.
    Estivill, Camino
    Pilar Sarda, M.
    Mateo, Jose
    Carles Souto, Joan
    Canals, Carme
    Nomdedeu, Josep
    Fontcuberta, Jordi
    HAEMATOLOGICA, 2007, 92 (02) : 285 - 286
12345